Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROFIL: Glycerol Phenylbutyrate in Corticobasal Syndrome
NCT05983588Phase 2Completed
- Sponsor
- Technical University of Munich
- Start
- Dec 2023
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sodium phenylbutyrate in Corticobasal Syndrome (CBS), sponsored by Technical University of Munich. Started Dec 2023; status: completed.
02
Drugs
sodium phenylbutyrate
03
Conditions
Corticobasal Syndrome (CBS)
Beyond the preview
Go deeper on NCT05983588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05983588.